235 related articles for article (PubMed ID: 33506646)
1. PMPC Modified PAMAM Dendrimer Enhances Brain Tumor-Targeted Drug Delivery.
Ban J; Li S; Zhan Q; Li X; Xing H; Chen N; Long L; Hou X; Zhao J; Yuan X
Macromol Biosci; 2021 Apr; 21(4):e2000392. PubMed ID: 33506646
[TBL] [Abstract][Full Text] [Related]
2. A novel doxorubicin loaded folic acid conjugated PAMAM modified with borneol, a nature dual-functional product of reducing PAMAM toxicity and boosting BBB penetration.
Xu X; Li J; Han S; Tao C; Fang L; Sun Y; Zhu J; Liang Z; Li F
Eur J Pharm Sci; 2016 Jun; 88():178-90. PubMed ID: 26965003
[TBL] [Abstract][Full Text] [Related]
3. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy.
Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X
Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865
[TBL] [Abstract][Full Text] [Related]
4. A dual-targeting nanocarrier based on poly(amidoamine) dendrimers conjugated with transferrin and tamoxifen for treating brain gliomas.
Li Y; He H; Jia X; Lu WL; Lou J; Wei Y
Biomaterials; 2012 May; 33(15):3899-908. PubMed ID: 22364698
[TBL] [Abstract][Full Text] [Related]
5. A novel RGDyC/PEG co-modified PAMAM dendrimer-loaded arsenic trioxide of glioma targeting delivery system.
Lu Y; Han S; Zheng H; Ma R; Ping Y; Zou J; Tang H; Zhang Y; Xu X; Li F
Int J Nanomedicine; 2018; 13():5937-5952. PubMed ID: 30323584
[TBL] [Abstract][Full Text] [Related]
6. A novel synergetic targeting strategy for glioma therapy employing borneol combination with angiopep-2-modified, DOX-loaded PAMAM dendrimer.
Han S; Zheng H; Lu Y; Sun Y; Huang A; Fei W; Shi X; Xu X; Li J; Li F
J Drug Target; 2018 Jan; 26(1):86-94. PubMed ID: 28635335
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
8. PEGylated Poly(amidoamine) dendrimer-based dual-targeting carrier for treating brain tumors.
He H; Li Y; Jia XR; Du J; Ying X; Lu WL; Lou JN; Wei Y
Biomaterials; 2011 Jan; 32(2):478-87. PubMed ID: 20934215
[TBL] [Abstract][Full Text] [Related]
9. Redox and pH dual responsive poly(amidoamine) dendrimer-poly(ethylene glycol) conjugates for intracellular delivery of doxorubicin.
Hu W; Qiu L; Cheng L; Hu Q; Liu Y; Hu Z; Chen D; Cheng L
Acta Biomater; 2016 May; 36():241-53. PubMed ID: 26995505
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
11. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
12. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
13. Effects of copolymer component on the properties of phosphorylcholine micelles.
Wu Z; Cai M; Cao J; Zhang J; Luo X
Int J Nanomedicine; 2017; 12():487-500. PubMed ID: 28138244
[TBL] [Abstract][Full Text] [Related]
14. PEGylated Polyamidoamine dendrimer conjugated with tumor homing peptide as a potential targeted delivery system for glioma.
Jiang Y; Lv L; Shi H; Hua Y; Lv W; Wang X; Xin H; Xu Q
Colloids Surf B Biointerfaces; 2016 Nov; 147():242-249. PubMed ID: 27518456
[TBL] [Abstract][Full Text] [Related]
15. iRGD and TGN co-modified PAMAM for multi-targeted delivery of ATO to gliomas.
Shi X; Ma R; Lu Y; Cheng Y; Fan X; Zou J; Zheng H; Li F; Piao JG
Biochem Biophys Res Commun; 2020 Jun; 527(1):117-123. PubMed ID: 32446354
[TBL] [Abstract][Full Text] [Related]
16. Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation.
Qiu X; Cao K; Lin T; Chen W; Yuan A; Wu J; Hu Y; Guo H
Int J Nanomedicine; 2017; 12():7365-7374. PubMed ID: 29066888
[TBL] [Abstract][Full Text] [Related]
17. [Preparation and in vitro evaluation of borneol and folic acid co-modified doxorubicin loaded PAMAM drug delivery system].
Li JJ; Guo MM; Han SP; Sun Y; Fei WD; Xu XI; Li FZ
Yao Xue Xue Bao; 2015 Jul; 50(7):899-905. PubMed ID: 26552154
[TBL] [Abstract][Full Text] [Related]
18. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
19. Label-Free Fluorescent Poly(amidoamine) Dendrimer for Traceable and Controlled Drug Delivery.
Wang G; Fu L; Walker A; Chen X; Lovejoy DB; Hao M; Lee A; Chung R; Rizos H; Irvine M; Zheng M; Liu X; Lu Y; Shi B
Biomacromolecules; 2019 May; 20(5):2148-2158. PubMed ID: 30995832
[TBL] [Abstract][Full Text] [Related]
20. Development of poly (I:C) modified doxorubicin loaded magnetic dendrimer nanoparticles for targeted combination therapy.
Khodadust R; Unsoy G; Gunduz U
Biomed Pharmacother; 2014 Oct; 68(8):979-87. PubMed ID: 25458787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
